Literature DB >> 8450163

Two-dimensional echocardiographic assessment of papillary muscle contractility in patients with prior myocardial infarction.

A Kisanuki1, Y Otsuji, R Kuroiwa, T Murayama, R Matsushita, K Shibata, T Yutsudo, S Nakao, K Nomoto, T Tomari.   

Abstract

OBJECTIVES: This study was performed to assess the length and contractile performance of human left ventricular papillary muscles and to determine the relation between papillary muscle dysfunction and mitral regurgitation.
BACKGROUND: Assessment of human papillary muscle contractility remains a clinical challenge.
METHODS: Two-dimensional echocardiographic examinations were performed in 16 normal subjects and 31 patients with prior myocardial infarction. Apical echocardiograms were used to obtain long-axis views of the anterior and posterior papillary muscles. The end-systolic and end-diastolic lengths of the papillary muscles were measured and fractional shortening was calculated.
RESULTS: Fractional shortening in normal subjects was 27 +/- 8% for the anterior papillary muscle and 30 +/- 8% for the posterior papillary muscle. In patients with prior myocardial infarction, a significant decrease in fractional shortening was observed in proportion to the severity of left ventricular wall motion abnormalities at the site of papillary muscle implantation. Moderate or severe mitral regurgitation was significantly more frequent in patients with combined anterior and posterior papillary muscle dysfunction than in those with isolated anterior or posterior dysfunction or with normal function of both papillary muscles (p < 0.05).
CONCLUSIONS: Two-dimensional echocardiography is useful for demonstrating abnormal contractility of human left ventricular papillary muscles. Papillary muscle contractility should be analyzed in each case to elucidate the mechanism of mitral regurgitation in patients with papillary muscle dysfunction.

Entities:  

Mesh:

Year:  1993        PMID: 8450163     DOI: 10.1016/0735-1097(93)90350-a

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  6 in total

1.  Mechanistic insights into functional mitral regurgitation.

Authors:  Robert A Levine; Judy Hung; Yutaka Otsuji; Emmanuel Messas; Noah Liel-Cohen; Nadia Nathan; Mark D Handschumacher; J Luis Guerrero; Shengqiu He; Ajit P Yoganathan; Gus J Vlahakes
Journal:  Curr Cardiol Rep       Date:  2002-03       Impact factor: 2.931

2.  Contribution of myocardium overlying the anterolateral papillary muscle to left ventricular deformation.

Authors:  Akinobu Itoh; Elizabeth H Stephens; Daniel B Ennis; Carl-Johan Carlhall; Wolfgang Bothe; Tom C Nguyen; Julia C Swanson; D Craig Miller; Neil B Ingels
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-10-28       Impact factor: 4.733

Review 3.  Exercise echocardiography for structural heart disease.

Authors:  Masaki Izumo; Yoshihiro J Akashi
Journal:  J Echocardiogr       Date:  2016-01-13

4.  Relationship between native papillary muscle T1 time and severity of functional mitral regurgitation in patients with non-ischemic dilated cardiomyopathy.

Authors:  Shingo Kato; Shiro Nakamori; Sébastien Roujol; Francesca N Delling; Shadi Akhtari; Jihye Jang; Tamer Basha; Sophie Berg; Kraig V Kissinger; Beth Goddu; Warren J Manning; Reza Nezafat
Journal:  J Cardiovasc Magn Reson       Date:  2016-11-16       Impact factor: 5.364

5.  Papillary Muscle Free Strain in Patients with Severe Degenerative and Functional Mitral Regurgitation.

Authors:  Alev Kılıcgedik; Gokhan Kahveci; Ahmet Seyfeddin Gurbuz; Can Yucel Karabay; Ahmet Guler; Suleyman Cagan Efe; Soe Moe Aung; Ugur Arslantas; Serdar Demir; Ibrahim Akin Izgi; Cevat Kirma
Journal:  Arq Bras Cardiol       Date:  2017-04       Impact factor: 2.000

6.  The genetic consequences of dog breed formation-Accumulation of deleterious genetic variation and fixation of mutations associated with myxomatous mitral valve disease in cavalier King Charles spaniels.

Authors:  Erik Axelsson; Ingrid Ljungvall; Priyasma Bhoumik; Laura Bas Conn; Eva Muren; Åsa Ohlsson; Lisbeth Høier Olsen; Karolina Engdahl; Ragnvi Hagman; Jeanette Hanson; Dmytro Kryvokhyzha; Mats Pettersson; Olivier Grenet; Jonathan Moggs; Alberto Del Rio-Espinola; Christian Epe; Bruce Taillon; Nilesh Tawari; Shrinivas Mane; Troy Hawkins; Åke Hedhammar; Philippe Gruet; Jens Häggström; Kerstin Lindblad-Toh
Journal:  PLoS Genet       Date:  2021-09-02       Impact factor: 5.917

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.